Literature DB >> 15271945

Interaction of Dr adhesin with collagen type IV is a critical step in Escherichia coli renal persistence.

Rangaraj Selvarangan1, Pawel Goluszko, Jyotsana Singhal, Christophe Carnoy, Steve Moseley, Billy Hudson, Stella Nowicki, Bogdan Nowicki.   

Abstract

The pathogenic mechanism of recurrent or chronic urinary tract infection is poorly understood. Escherichia coli cells bearing Dr fimbriae display unique tropism to the basement membrane (BM)-renal interstitium that enables the bacteria to cause chronic pyelonephritis in experimental mice. The renal receptors for Dr-fimbriated E. coli are type IV collagen and decay-accelerating factor (DAF). We hypothesized that type IV collagen receptor-mediated BM-interstitial tropism is essential for E. coli to cause chronic pyelonephritis. To test the role of the type IV collagen tropism of Dr-fimbriated E. coli in renal persistence, we constructed an isogenic mutant in the DraE adhesin subunit that was unable to bind type IV collagen but retained binding to DAF and examined its virulence in the mouse model. The collagen-binding mutant DrI113T was eliminated from the mouse renal tissues in 6 to 8 weeks, while the parent strain caused persistent renal infection that lasted at least 14 weeks (P < or = 0.02). Transcomplementation with the intact Dr operon restored collagen-binding activity, BM-interstitial tropism, and the ability to cause persistent renal infection. We conclude that type IV collagen binding mediated by DraE adhesin is a critical step for the development of persistent renal infection in a murine model of E. coli pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271945      PMCID: PMC470682          DOI: 10.1128/IAI.72.8.4827-4835.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness.

Authors:  B Nowicki; R Selvarangan; S Nowicki
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

2.  Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line.

Authors:  P Goluszko; V Popov; R Selvarangan; S Nowicki; T Pham; B J Nowicki
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

3.  Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells.

Authors:  K Dziewanowska; J M Patti; C F Deobald; K W Bayles; W R Trumble; G A Bohach
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Entry of OpaA+ gonococci into HEp-2 cells requires concerted action of glycosaminoglycans, fibronectin and integrin receptors.

Authors:  J P van Putten; T D Duensing; R L Cole
Journal:  Mol Microbiol       Date:  1998-07       Impact factor: 3.501

5.  Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.

Authors:  M A Mulvey; Y S Lopez-Boado; C L Wilson; R Roth; W C Parks; J Heuser; S J Hultgren
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

6.  Diversity of the Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and uroepithelial cells.

Authors:  E V Sokurenko; V Chesnokova; R J Doyle; D L Hasty
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

7.  Prevalence of enteropathogenic, enteroaggregative, and diffusely adherent Escherichia coli among isolates from children with diarrhea in new Caledonia.

Authors:  Y Germani; E Bégaud; P Duval; C Le Bouguénec
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

8.  Role of decay-accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coli.

Authors:  R Selvarangan; P Goluszko; V Popov; J Singhal; T Pham; D M Lublin; S Nowicki; B Nowicki
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

9.  Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis.

Authors:  P Goluszko; S L Moseley; L D Truong; A Kaul; J R Williford; R Selvarangan; S Nowicki; B Nowicki
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

10.  Apoptosis of human intestinal epithelial cells after bacterial invasion.

Authors:  J M Kim; L Eckmann; T C Savidge; D C Lowe; T Witthöft; M F Kagnoff
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

View more
  17 in total

Review 1.  Covert operations of uropathogenic Escherichia coli within the urinary tract.

Authors:  Jean M Bower; Danelle S Eto; Matthew A Mulvey
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

2.  Vaccination with purified Dr Fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesin.

Authors:  Pawel Goluszko; Elzbieta Goluszko; Bogdan Nowicki; Stella Nowicki; Vsevolod Popov; Hui-Qun Wang
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract.

Authors:  M Chelsea Lane; Virginia Lockatell; Greta Monterosso; Daniel Lamphier; Julia Weinert; J Richard Hebel; David E Johnson; Harry L T Mobley
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 4.  Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.

Authors:  J Des Parkin; James D San Antonio; Vadim Pedchenko; Billy Hudson; Shane T Jensen; Judy Savige
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

5.  Glutamine synthetase and glucose-6-phosphate isomerase are adhesive moonlighting proteins of Lactobacillus crispatus released by epithelial cathelicidin LL-37.

Authors:  Veera Kainulainen; Vuokko Loimaranta; Anna Pekkala; Sanna Edelman; Jenni Antikainen; Riikka Kylväjä; Maiju Laaksonen; Liisa Laakkonen; Jukka Finne; Timo K Korhonen
Journal:  J Bacteriol       Date:  2012-03-02       Impact factor: 3.490

Review 6.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 7.  Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes.

Authors:  Jennifer A Jolley; Deborah A Wing
Journal:  Drugs       Date:  2010-09-10       Impact factor: 9.546

Review 8.  Antimicrobial mechanisms of the urinary tract.

Authors:  Milan Chromek; Annelie Brauner
Journal:  J Mol Med (Berl)       Date:  2007-09-06       Impact factor: 4.599

9.  Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli.

Authors:  Ruth E Berry; David J Klumpp; Anthony J Schaeffer
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

Review 10.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.